nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Nilutamide—prostate cancer	0.101	0.192	CbGbCtD
Flecainide—CYP2C9—Bicalutamide—prostate cancer	0.101	0.192	CbGbCtD
Flecainide—CYP2D6—Bicalutamide—prostate cancer	0.0924	0.176	CbGbCtD
Flecainide—CYP2D6—Abiraterone—prostate cancer	0.0766	0.145	CbGbCtD
Flecainide—CYP2C9—Estrone—prostate cancer	0.0605	0.115	CbGbCtD
Flecainide—CYP2C9—Capecitabine—prostate cancer	0.0459	0.0871	CbGbCtD
Flecainide—CYP2C9—Estradiol—prostate cancer	0.0348	0.066	CbGbCtD
Flecainide—CYP2D6—Doxorubicin—prostate cancer	0.0142	0.0269	CbGbCtD
Flecainide—Mefloquine—ACHE—prostate cancer	0.0047	0.536	CrCbGaD
Flecainide—Mefloquine—CYP19A1—prostate cancer	0.00277	0.316	CrCbGaD
Flecainide—Mefloquine—CYP3A4—prostate cancer	0.0013	0.148	CrCbGaD
Flecainide—Bradycardia—Epirubicin—prostate cancer	0.000119	0.000346	CcSEcCtD
Flecainide—Renal failure—Doxorubicin—prostate cancer	0.000118	0.000345	CcSEcCtD
Flecainide—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000118	0.000344	CcSEcCtD
Flecainide—Urticaria—Etoposide—prostate cancer	0.000118	0.000343	CcSEcCtD
Flecainide—Jaundice—Doxorubicin—prostate cancer	0.000117	0.000342	CcSEcCtD
Flecainide—Anorexia—Docetaxel—prostate cancer	0.000117	0.000342	CcSEcCtD
Flecainide—Malaise—Prednisone—prostate cancer	0.000117	0.000342	CcSEcCtD
Flecainide—Shock—Capecitabine—prostate cancer	0.000117	0.000341	CcSEcCtD
Flecainide—Body temperature increased—Etoposide—prostate cancer	0.000117	0.000341	CcSEcCtD
Flecainide—Abdominal pain—Etoposide—prostate cancer	0.000117	0.000341	CcSEcCtD
Flecainide—Nervous system disorder—Capecitabine—prostate cancer	0.000117	0.00034	CcSEcCtD
Flecainide—Vertigo—Prednisone—prostate cancer	0.000117	0.00034	CcSEcCtD
Flecainide—Thrombocytopenia—Capecitabine—prostate cancer	0.000117	0.00034	CcSEcCtD
Flecainide—Syncope—Prednisone—prostate cancer	0.000117	0.00034	CcSEcCtD
Flecainide—Tachycardia—Capecitabine—prostate cancer	0.000116	0.000339	CcSEcCtD
Flecainide—Hypoaesthesia—Epirubicin—prostate cancer	0.000116	0.000339	CcSEcCtD
Flecainide—Skin disorder—Capecitabine—prostate cancer	0.000116	0.000337	CcSEcCtD
Flecainide—Hyperhidrosis—Capecitabine—prostate cancer	0.000115	0.000335	CcSEcCtD
Flecainide—Hypotension—Docetaxel—prostate cancer	0.000115	0.000335	CcSEcCtD
Flecainide—Haematuria—Doxorubicin—prostate cancer	0.000115	0.000334	CcSEcCtD
Flecainide—Loss of consciousness—Prednisone—prostate cancer	0.000114	0.000333	CcSEcCtD
Flecainide—Anorexia—Capecitabine—prostate cancer	0.000114	0.000331	CcSEcCtD
Flecainide—Nausea—Estradiol—prostate cancer	0.000114	0.000331	CcSEcCtD
Flecainide—Vomiting—Mitoxantrone—prostate cancer	0.000113	0.00033	CcSEcCtD
Flecainide—Convulsion—Prednisone—prostate cancer	0.000113	0.000328	CcSEcCtD
Flecainide—Visual impairment—Epirubicin—prostate cancer	0.000113	0.000328	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—prostate cancer	0.000112	0.000327	CcSEcCtD
Flecainide—Hypertension—Prednisone—prostate cancer	0.000112	0.000327	CcSEcCtD
Flecainide—Rash—Mitoxantrone—prostate cancer	0.000112	0.000327	CcSEcCtD
Flecainide—Dermatitis—Mitoxantrone—prostate cancer	0.000112	0.000327	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000112	0.000327	CcSEcCtD
Flecainide—Headache—Mitoxantrone—prostate cancer	0.000112	0.000325	CcSEcCtD
Flecainide—Hypotension—Capecitabine—prostate cancer	0.000111	0.000324	CcSEcCtD
Flecainide—Insomnia—Docetaxel—prostate cancer	0.000111	0.000324	CcSEcCtD
Flecainide—Myalgia—Prednisone—prostate cancer	0.000111	0.000322	CcSEcCtD
Flecainide—Arthralgia—Prednisone—prostate cancer	0.000111	0.000322	CcSEcCtD
Flecainide—Paraesthesia—Docetaxel—prostate cancer	0.000111	0.000322	CcSEcCtD
Flecainide—Anxiety—Prednisone—prostate cancer	0.00011	0.000321	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—prostate cancer	0.00011	0.000321	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00011	0.00032	CcSEcCtD
Flecainide—Dyspnoea—Docetaxel—prostate cancer	0.00011	0.00032	CcSEcCtD
Flecainide—Somnolence—Docetaxel—prostate cancer	0.000109	0.000319	CcSEcCtD
Flecainide—Discomfort—Prednisone—prostate cancer	0.000109	0.000319	CcSEcCtD
Flecainide—Eye disorder—Epirubicin—prostate cancer	0.000109	0.000318	CcSEcCtD
Flecainide—Tinnitus—Epirubicin—prostate cancer	0.000109	0.000317	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000109	0.000316	CcSEcCtD
Flecainide—Flushing—Epirubicin—prostate cancer	0.000108	0.000316	CcSEcCtD
Flecainide—Dyspepsia—Docetaxel—prostate cancer	0.000108	0.000315	CcSEcCtD
Flecainide—Insomnia—Capecitabine—prostate cancer	0.000108	0.000314	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—prostate cancer	0.000108	0.000313	CcSEcCtD
Flecainide—Paraesthesia—Capecitabine—prostate cancer	0.000107	0.000312	CcSEcCtD
Flecainide—Decreased appetite—Docetaxel—prostate cancer	0.000107	0.000312	CcSEcCtD
Flecainide—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000106	0.000309	CcSEcCtD
Flecainide—Asthenia—Etoposide—prostate cancer	0.000106	0.000309	CcSEcCtD
Flecainide—Dyspnoea—Capecitabine—prostate cancer	0.000106	0.000309	CcSEcCtD
Flecainide—Oedema—Prednisone—prostate cancer	0.000106	0.000309	CcSEcCtD
Flecainide—Fatigue—Docetaxel—prostate cancer	0.000106	0.000309	CcSEcCtD
Flecainide—Nausea—Mitoxantrone—prostate cancer	0.000106	0.000308	CcSEcCtD
Flecainide—Immune system disorder—Epirubicin—prostate cancer	0.000106	0.000307	CcSEcCtD
Flecainide—Pain—Docetaxel—prostate cancer	0.000105	0.000306	CcSEcCtD
Flecainide—Constipation—Docetaxel—prostate cancer	0.000105	0.000306	CcSEcCtD
Flecainide—Dyspepsia—Capecitabine—prostate cancer	0.000105	0.000305	CcSEcCtD
Flecainide—Pruritus—Etoposide—prostate cancer	0.000105	0.000305	CcSEcCtD
Flecainide—Shock—Prednisone—prostate cancer	0.000104	0.000304	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—prostate cancer	0.000104	0.000303	CcSEcCtD
Flecainide—Nervous system disorder—Prednisone—prostate cancer	0.000104	0.000303	CcSEcCtD
Flecainide—Tachycardia—Prednisone—prostate cancer	0.000104	0.000302	CcSEcCtD
Flecainide—Decreased appetite—Capecitabine—prostate cancer	0.000104	0.000302	CcSEcCtD
Flecainide—Alopecia—Epirubicin—prostate cancer	0.000103	0.000301	CcSEcCtD
Flecainide—Skin disorder—Prednisone—prostate cancer	0.000103	0.0003	CcSEcCtD
Flecainide—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000103	0.0003	CcSEcCtD
Flecainide—Fatigue—Capecitabine—prostate cancer	0.000103	0.000299	CcSEcCtD
Flecainide—Hyperhidrosis—Prednisone—prostate cancer	0.000103	0.000299	CcSEcCtD
Flecainide—Pain—Capecitabine—prostate cancer	0.000102	0.000297	CcSEcCtD
Flecainide—Constipation—Capecitabine—prostate cancer	0.000102	0.000297	CcSEcCtD
Flecainide—Feeling abnormal—Docetaxel—prostate cancer	0.000101	0.000295	CcSEcCtD
Flecainide—Diarrhoea—Etoposide—prostate cancer	0.000101	0.000295	CcSEcCtD
Flecainide—Anorexia—Prednisone—prostate cancer	0.000101	0.000295	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—prostate cancer	0.000101	0.000294	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—prostate cancer	0.000101	0.000294	CcSEcCtD
Flecainide—Gastrointestinal pain—Docetaxel—prostate cancer	0.000101	0.000293	CcSEcCtD
Flecainide—Flushing—Doxorubicin—prostate cancer	0.0001	0.000292	CcSEcCtD
Flecainide—Flatulence—Epirubicin—prostate cancer	0.0001	0.000292	CcSEcCtD
Flecainide—Tension—Epirubicin—prostate cancer	9.98e-05	0.000291	CcSEcCtD
Flecainide—Dysgeusia—Epirubicin—prostate cancer	9.96e-05	0.00029	CcSEcCtD
Flecainide—Nervousness—Epirubicin—prostate cancer	9.88e-05	0.000288	CcSEcCtD
Flecainide—Feeling abnormal—Capecitabine—prostate cancer	9.82e-05	0.000286	CcSEcCtD
Flecainide—Dizziness—Etoposide—prostate cancer	9.8e-05	0.000285	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—prostate cancer	9.77e-05	0.000284	CcSEcCtD
Flecainide—Gastrointestinal pain—Capecitabine—prostate cancer	9.75e-05	0.000284	CcSEcCtD
Flecainide—Abdominal pain—Docetaxel—prostate cancer	9.73e-05	0.000283	CcSEcCtD
Flecainide—Body temperature increased—Docetaxel—prostate cancer	9.73e-05	0.000283	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Prednisone—prostate cancer	9.67e-05	0.000282	CcSEcCtD
Flecainide—Insomnia—Prednisone—prostate cancer	9.6e-05	0.00028	CcSEcCtD
Flecainide—Vision blurred—Epirubicin—prostate cancer	9.59e-05	0.000279	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—prostate cancer	9.56e-05	0.000278	CcSEcCtD
Flecainide—Paraesthesia—Prednisone—prostate cancer	9.53e-05	0.000278	CcSEcCtD
Flecainide—Urticaria—Capecitabine—prostate cancer	9.47e-05	0.000276	CcSEcCtD
Flecainide—Ill-defined disorder—Epirubicin—prostate cancer	9.44e-05	0.000275	CcSEcCtD
Flecainide—Body temperature increased—Capecitabine—prostate cancer	9.42e-05	0.000274	CcSEcCtD
Flecainide—Abdominal pain—Capecitabine—prostate cancer	9.42e-05	0.000274	CcSEcCtD
Flecainide—Vomiting—Etoposide—prostate cancer	9.42e-05	0.000274	CcSEcCtD
Flecainide—Dyspepsia—Prednisone—prostate cancer	9.35e-05	0.000272	CcSEcCtD
Flecainide—Rash—Etoposide—prostate cancer	9.34e-05	0.000272	CcSEcCtD
Flecainide—Dermatitis—Etoposide—prostate cancer	9.33e-05	0.000272	CcSEcCtD
Flecainide—Headache—Etoposide—prostate cancer	9.28e-05	0.00027	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—prostate cancer	9.28e-05	0.00027	CcSEcCtD
Flecainide—Tension—Doxorubicin—prostate cancer	9.24e-05	0.000269	CcSEcCtD
Flecainide—Decreased appetite—Prednisone—prostate cancer	9.23e-05	0.000269	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—prostate cancer	9.22e-05	0.000268	CcSEcCtD
Flecainide—Malaise—Epirubicin—prostate cancer	9.18e-05	0.000267	CcSEcCtD
Flecainide—Fatigue—Prednisone—prostate cancer	9.15e-05	0.000266	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—prostate cancer	9.14e-05	0.000266	CcSEcCtD
Flecainide—Vertigo—Epirubicin—prostate cancer	9.14e-05	0.000266	CcSEcCtD
Flecainide—Syncope—Epirubicin—prostate cancer	9.12e-05	0.000266	CcSEcCtD
Flecainide—Leukopenia—Epirubicin—prostate cancer	9.11e-05	0.000265	CcSEcCtD
Flecainide—Constipation—Prednisone—prostate cancer	9.08e-05	0.000264	CcSEcCtD
Flecainide—Palpitations—Epirubicin—prostate cancer	8.99e-05	0.000262	CcSEcCtD
Flecainide—Loss of consciousness—Epirubicin—prostate cancer	8.94e-05	0.00026	CcSEcCtD
Flecainide—Cough—Epirubicin—prostate cancer	8.88e-05	0.000258	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—prostate cancer	8.87e-05	0.000258	CcSEcCtD
Flecainide—Asthenia—Docetaxel—prostate cancer	8.83e-05	0.000257	CcSEcCtD
Flecainide—Convulsion—Epirubicin—prostate cancer	8.82e-05	0.000257	CcSEcCtD
Flecainide—Nausea—Etoposide—prostate cancer	8.8e-05	0.000256	CcSEcCtD
Flecainide—Hypertension—Epirubicin—prostate cancer	8.78e-05	0.000256	CcSEcCtD
Flecainide—Feeling abnormal—Prednisone—prostate cancer	8.75e-05	0.000255	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—prostate cancer	8.74e-05	0.000254	CcSEcCtD
Flecainide—Pruritus—Docetaxel—prostate cancer	8.71e-05	0.000254	CcSEcCtD
Flecainide—Gastrointestinal pain—Prednisone—prostate cancer	8.68e-05	0.000253	CcSEcCtD
Flecainide—Myalgia—Epirubicin—prostate cancer	8.66e-05	0.000252	CcSEcCtD
Flecainide—Arthralgia—Epirubicin—prostate cancer	8.66e-05	0.000252	CcSEcCtD
Flecainide—Chest pain—Epirubicin—prostate cancer	8.66e-05	0.000252	CcSEcCtD
Flecainide—Anxiety—Epirubicin—prostate cancer	8.63e-05	0.000251	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.6e-05	0.00025	CcSEcCtD
Flecainide—Discomfort—Epirubicin—prostate cancer	8.56e-05	0.000249	CcSEcCtD
Flecainide—Asthenia—Capecitabine—prostate cancer	8.55e-05	0.000249	CcSEcCtD
Flecainide—Malaise—Doxorubicin—prostate cancer	8.49e-05	0.000247	CcSEcCtD
Flecainide—Dry mouth—Epirubicin—prostate cancer	8.47e-05	0.000247	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—prostate cancer	8.46e-05	0.000246	CcSEcCtD
Flecainide—Syncope—Doxorubicin—prostate cancer	8.44e-05	0.000246	CcSEcCtD
Flecainide—Urticaria—Prednisone—prostate cancer	8.44e-05	0.000246	CcSEcCtD
Flecainide—Pruritus—Capecitabine—prostate cancer	8.43e-05	0.000246	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—prostate cancer	8.43e-05	0.000245	CcSEcCtD
Flecainide—Diarrhoea—Docetaxel—prostate cancer	8.42e-05	0.000245	CcSEcCtD
Flecainide—Abdominal pain—Prednisone—prostate cancer	8.39e-05	0.000244	CcSEcCtD
Flecainide—Body temperature increased—Prednisone—prostate cancer	8.39e-05	0.000244	CcSEcCtD
Flecainide—Confusional state—Epirubicin—prostate cancer	8.37e-05	0.000244	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—prostate cancer	8.32e-05	0.000242	CcSEcCtD
Flecainide—Oedema—Epirubicin—prostate cancer	8.3e-05	0.000242	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—prostate cancer	8.27e-05	0.000241	CcSEcCtD
Flecainide—Cough—Doxorubicin—prostate cancer	8.22e-05	0.000239	CcSEcCtD
Flecainide—Shock—Epirubicin—prostate cancer	8.17e-05	0.000238	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—prostate cancer	8.16e-05	0.000237	CcSEcCtD
Flecainide—Diarrhoea—Capecitabine—prostate cancer	8.16e-05	0.000237	CcSEcCtD
Flecainide—Nervous system disorder—Epirubicin—prostate cancer	8.14e-05	0.000237	CcSEcCtD
Flecainide—Dizziness—Docetaxel—prostate cancer	8.14e-05	0.000237	CcSEcCtD
Flecainide—Thrombocytopenia—Epirubicin—prostate cancer	8.13e-05	0.000237	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—prostate cancer	8.13e-05	0.000237	CcSEcCtD
Flecainide—Tachycardia—Epirubicin—prostate cancer	8.1e-05	0.000236	CcSEcCtD
Flecainide—Skin disorder—Epirubicin—prostate cancer	8.07e-05	0.000235	CcSEcCtD
Flecainide—Hyperhidrosis—Epirubicin—prostate cancer	8.03e-05	0.000234	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—prostate cancer	8.02e-05	0.000233	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—prostate cancer	8.02e-05	0.000233	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—prostate cancer	8.02e-05	0.000233	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—prostate cancer	7.99e-05	0.000233	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.96e-05	0.000232	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—prostate cancer	7.92e-05	0.000231	CcSEcCtD
Flecainide—Anorexia—Epirubicin—prostate cancer	7.92e-05	0.00023	CcSEcCtD
Flecainide—Dizziness—Capecitabine—prostate cancer	7.88e-05	0.000229	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—prostate cancer	7.84e-05	0.000228	CcSEcCtD
Flecainide—Vomiting—Docetaxel—prostate cancer	7.83e-05	0.000228	CcSEcCtD
Flecainide—Rash—Docetaxel—prostate cancer	7.76e-05	0.000226	CcSEcCtD
Flecainide—Hypotension—Epirubicin—prostate cancer	7.76e-05	0.000226	CcSEcCtD
Flecainide—Dermatitis—Docetaxel—prostate cancer	7.76e-05	0.000226	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—prostate cancer	7.75e-05	0.000226	CcSEcCtD
Flecainide—Headache—Docetaxel—prostate cancer	7.71e-05	0.000225	CcSEcCtD
Flecainide—Oedema—Doxorubicin—prostate cancer	7.68e-05	0.000224	CcSEcCtD
Flecainide—Asthenia—Prednisone—prostate cancer	7.62e-05	0.000222	CcSEcCtD
Flecainide—Vomiting—Capecitabine—prostate cancer	7.58e-05	0.000221	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Epirubicin—prostate cancer	7.57e-05	0.00022	CcSEcCtD
Flecainide—Shock—Doxorubicin—prostate cancer	7.56e-05	0.00022	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—prostate cancer	7.54e-05	0.000219	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—prostate cancer	7.52e-05	0.000219	CcSEcCtD
Flecainide—Rash—Capecitabine—prostate cancer	7.52e-05	0.000219	CcSEcCtD
Flecainide—Pruritus—Prednisone—prostate cancer	7.51e-05	0.000219	CcSEcCtD
Flecainide—Insomnia—Epirubicin—prostate cancer	7.51e-05	0.000219	CcSEcCtD
Flecainide—Dermatitis—Capecitabine—prostate cancer	7.51e-05	0.000219	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—prostate cancer	7.5e-05	0.000218	CcSEcCtD
Flecainide—Headache—Capecitabine—prostate cancer	7.47e-05	0.000217	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—prostate cancer	7.46e-05	0.000217	CcSEcCtD
Flecainide—Paraesthesia—Epirubicin—prostate cancer	7.46e-05	0.000217	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—prostate cancer	7.43e-05	0.000216	CcSEcCtD
Flecainide—Dyspnoea—Epirubicin—prostate cancer	7.4e-05	0.000216	CcSEcCtD
Flecainide—Somnolence—Epirubicin—prostate cancer	7.38e-05	0.000215	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—prostate cancer	7.32e-05	0.000213	CcSEcCtD
Flecainide—Nausea—Docetaxel—prostate cancer	7.31e-05	0.000213	CcSEcCtD
Flecainide—Dyspepsia—Epirubicin—prostate cancer	7.31e-05	0.000213	CcSEcCtD
Flecainide—Diarrhoea—Prednisone—prostate cancer	7.26e-05	0.000211	CcSEcCtD
Flecainide—Decreased appetite—Epirubicin—prostate cancer	7.22e-05	0.00021	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—prostate cancer	7.18e-05	0.000209	CcSEcCtD
Flecainide—Gastrointestinal disorder—Epirubicin—prostate cancer	7.17e-05	0.000209	CcSEcCtD
Flecainide—Fatigue—Epirubicin—prostate cancer	7.16e-05	0.000208	CcSEcCtD
Flecainide—Constipation—Epirubicin—prostate cancer	7.1e-05	0.000207	CcSEcCtD
Flecainide—Pain—Epirubicin—prostate cancer	7.1e-05	0.000207	CcSEcCtD
Flecainide—Nausea—Capecitabine—prostate cancer	7.08e-05	0.000206	CcSEcCtD
Flecainide—Dizziness—Prednisone—prostate cancer	7.02e-05	0.000204	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7e-05	0.000204	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—prostate cancer	6.95e-05	0.000202	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—prostate cancer	6.9e-05	0.000201	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—prostate cancer	6.85e-05	0.000199	CcSEcCtD
Flecainide—Feeling abnormal—Epirubicin—prostate cancer	6.84e-05	0.000199	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—prostate cancer	6.83e-05	0.000199	CcSEcCtD
Flecainide—Gastrointestinal pain—Epirubicin—prostate cancer	6.79e-05	0.000198	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—prostate cancer	6.76e-05	0.000197	CcSEcCtD
Flecainide—Vomiting—Prednisone—prostate cancer	6.75e-05	0.000197	CcSEcCtD
Flecainide—Rash—Prednisone—prostate cancer	6.69e-05	0.000195	CcSEcCtD
Flecainide—Dermatitis—Prednisone—prostate cancer	6.69e-05	0.000195	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—prostate cancer	6.68e-05	0.000194	CcSEcCtD
Flecainide—Headache—Prednisone—prostate cancer	6.65e-05	0.000194	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.63e-05	0.000193	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—prostate cancer	6.62e-05	0.000193	CcSEcCtD
Flecainide—Urticaria—Epirubicin—prostate cancer	6.6e-05	0.000192	CcSEcCtD
Flecainide—Pain—Doxorubicin—prostate cancer	6.57e-05	0.000191	CcSEcCtD
Flecainide—Constipation—Doxorubicin—prostate cancer	6.57e-05	0.000191	CcSEcCtD
Flecainide—Abdominal pain—Epirubicin—prostate cancer	6.56e-05	0.000191	CcSEcCtD
Flecainide—Body temperature increased—Epirubicin—prostate cancer	6.56e-05	0.000191	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—prostate cancer	6.33e-05	0.000184	CcSEcCtD
Flecainide—Nausea—Prednisone—prostate cancer	6.31e-05	0.000184	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—prostate cancer	6.28e-05	0.000183	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—prostate cancer	6.1e-05	0.000178	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—prostate cancer	6.07e-05	0.000177	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—prostate cancer	6.07e-05	0.000177	CcSEcCtD
Flecainide—Asthenia—Epirubicin—prostate cancer	5.96e-05	0.000173	CcSEcCtD
Flecainide—Pruritus—Epirubicin—prostate cancer	5.88e-05	0.000171	CcSEcCtD
Flecainide—Diarrhoea—Epirubicin—prostate cancer	5.68e-05	0.000165	CcSEcCtD
Flecainide—Asthenia—Doxorubicin—prostate cancer	5.51e-05	0.00016	CcSEcCtD
Flecainide—Dizziness—Epirubicin—prostate cancer	5.49e-05	0.00016	CcSEcCtD
Flecainide—Pruritus—Doxorubicin—prostate cancer	5.44e-05	0.000158	CcSEcCtD
Flecainide—Vomiting—Epirubicin—prostate cancer	5.28e-05	0.000154	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—prostate cancer	5.26e-05	0.000153	CcSEcCtD
Flecainide—Rash—Epirubicin—prostate cancer	5.24e-05	0.000152	CcSEcCtD
Flecainide—Dermatitis—Epirubicin—prostate cancer	5.23e-05	0.000152	CcSEcCtD
Flecainide—Headache—Epirubicin—prostate cancer	5.2e-05	0.000151	CcSEcCtD
Flecainide—Dizziness—Doxorubicin—prostate cancer	5.08e-05	0.000148	CcSEcCtD
Flecainide—Nausea—Epirubicin—prostate cancer	4.93e-05	0.000144	CcSEcCtD
Flecainide—Vomiting—Doxorubicin—prostate cancer	4.89e-05	0.000142	CcSEcCtD
Flecainide—Rash—Doxorubicin—prostate cancer	4.84e-05	0.000141	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—prostate cancer	4.84e-05	0.000141	CcSEcCtD
Flecainide—Headache—Doxorubicin—prostate cancer	4.81e-05	0.00014	CcSEcCtD
Flecainide—Nausea—Doxorubicin—prostate cancer	4.56e-05	0.000133	CcSEcCtD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	4.14e-05	0.000341	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—KRAS—prostate cancer	4.13e-05	0.000341	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CBR1—prostate cancer	4.09e-05	0.000338	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CSAD—prostate cancer	4.09e-05	0.000338	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GRHL1—prostate cancer	4.09e-05	0.000338	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PSAT1—prostate cancer	4.09e-05	0.000338	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TST—prostate cancer	4.09e-05	0.000338	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ADI1—prostate cancer	4.09e-05	0.000338	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GRHL1—prostate cancer	4.06e-05	0.000335	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CBR1—prostate cancer	4.06e-05	0.000335	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CSAD—prostate cancer	4.06e-05	0.000335	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PSAT1—prostate cancer	4.06e-05	0.000335	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TST—prostate cancer	4.06e-05	0.000335	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ADI1—prostate cancer	4.06e-05	0.000335	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	3.97e-05	0.000327	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—KRAS—prostate cancer	3.92e-05	0.000324	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	3.89e-05	0.000321	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CKMT2—prostate cancer	3.81e-05	0.000314	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GRHPR—prostate cancer	3.81e-05	0.000314	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UGT2B15—prostate cancer	3.81e-05	0.000314	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UGT2B17—prostate cancer	3.81e-05	0.000314	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UGT2B17—prostate cancer	3.77e-05	0.000311	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UGT2B15—prostate cancer	3.77e-05	0.000311	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GRHPR—prostate cancer	3.77e-05	0.000311	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CKMT2—prostate cancer	3.77e-05	0.000311	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CTNNB1—prostate cancer	3.74e-05	0.000309	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	3.69e-05	0.000304	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MMP9—prostate cancer	3.67e-05	0.000303	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	3.63e-05	0.000299	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTM3—prostate cancer	3.58e-05	0.000295	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NAGLU—prostate cancer	3.58e-05	0.000295	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MBTPS1—prostate cancer	3.58e-05	0.000295	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SULT2B1—prostate cancer	3.58e-05	0.000295	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PGAM2—prostate cancer	3.58e-05	0.000295	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—RFK—prostate cancer	3.58e-05	0.000295	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AOX1—prostate cancer	3.58e-05	0.000295	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AOX1—prostate cancer	3.55e-05	0.000293	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SULT2B1—prostate cancer	3.55e-05	0.000293	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MBTPS1—prostate cancer	3.55e-05	0.000293	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTM3—prostate cancer	3.55e-05	0.000293	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—RFK—prostate cancer	3.55e-05	0.000293	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PGAM2—prostate cancer	3.55e-05	0.000293	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NAGLU—prostate cancer	3.55e-05	0.000293	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—EP300—prostate cancer	3.48e-05	0.000287	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.47e-05	0.000286	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—DEGS1—prostate cancer	3.39e-05	0.00028	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SRD5A2—prostate cancer	3.39e-05	0.00028	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AMACR—prostate cancer	3.39e-05	0.00028	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP3A43—prostate cancer	3.39e-05	0.00028	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NAT1—prostate cancer	3.39e-05	0.00028	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SRC—prostate cancer	3.38e-05	0.000279	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AMACR—prostate cancer	3.36e-05	0.000278	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NAT1—prostate cancer	3.36e-05	0.000278	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP3A43—prostate cancer	3.36e-05	0.000278	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—DEGS1—prostate cancer	3.36e-05	0.000278	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SRD5A2—prostate cancer	3.36e-05	0.000278	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—IL6—prostate cancer	3.36e-05	0.000277	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.31e-05	0.000273	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—VEGFA—prostate cancer	3.29e-05	0.000272	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	3.29e-05	0.000271	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—STAT3—prostate cancer	3.26e-05	0.000269	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD17B1—prostate cancer	3.24e-05	0.000267	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD17B1—prostate cancer	3.21e-05	0.000265	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.21e-05	0.000265	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—IL6—prostate cancer	3.19e-05	0.000263	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT1—prostate cancer	3.1e-05	0.000256	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.08e-05	0.000255	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.07e-05	0.000253	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.04e-05	0.000251	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TGFB1—prostate cancer	3.02e-05	0.000249	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—EGFR—prostate cancer	2.96e-05	0.000244	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	2.89e-05	0.000239	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—B4GALT4—prostate cancer	2.88e-05	0.000238	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HPGD—prostate cancer	2.88e-05	0.000238	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HPGD—prostate cancer	2.86e-05	0.000236	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—B4GALT4—prostate cancer	2.86e-05	0.000236	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—KRAS—prostate cancer	2.8e-05	0.000231	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TNFRSF21—prostate cancer	2.71e-05	0.000224	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TNFRSF21—prostate cancer	2.69e-05	0.000222	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTAP—prostate cancer	2.64e-05	0.000218	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP7B1—prostate cancer	2.64e-05	0.000218	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP7B1—prostate cancer	2.62e-05	0.000216	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTAP—prostate cancer	2.62e-05	0.000216	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SULT1E1—prostate cancer	2.57e-05	0.000212	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SRD5A1—prostate cancer	2.57e-05	0.000212	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.56e-05	0.000211	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SULT1E1—prostate cancer	2.55e-05	0.00021	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SRD5A1—prostate cancer	2.55e-05	0.00021	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.48e-05	0.000204	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ACSL4—prostate cancer	2.45e-05	0.000202	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD17B3—prostate cancer	2.45e-05	0.000202	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.44e-05	0.000201	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ACSL4—prostate cancer	2.43e-05	0.000201	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD17B3—prostate cancer	2.43e-05	0.000201	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.4e-05	0.000198	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ARG2—prostate cancer	2.35e-05	0.000194	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UMPS—prostate cancer	2.35e-05	0.000194	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PHGDH—prostate cancer	2.35e-05	0.000194	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ARG2—prostate cancer	2.33e-05	0.000192	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UMPS—prostate cancer	2.33e-05	0.000192	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PHGDH—prostate cancer	2.33e-05	0.000192	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.32e-05	0.000191	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LDHB—prostate cancer	2.31e-05	0.00019	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LDHB—prostate cancer	2.29e-05	0.000189	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—IL6—prostate cancer	2.28e-05	0.000188	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP3A5—prostate cancer	2.26e-05	0.000187	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP3A5—prostate cancer	2.24e-05	0.000185	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UCP3—prostate cancer	2.19e-05	0.00018	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PDHA1—prostate cancer	2.19e-05	0.00018	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA3—prostate cancer	2.19e-05	0.00018	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TCN2—prostate cancer	2.19e-05	0.00018	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PDHA1—prostate cancer	2.17e-05	0.000179	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TCN2—prostate cancer	2.17e-05	0.000179	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UCP3—prostate cancer	2.17e-05	0.000179	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA3—prostate cancer	2.17e-05	0.000179	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT1—prostate cancer	2.1e-05	0.000173	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD3B1—prostate cancer	2.09e-05	0.000172	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC22A3—prostate cancer	2.09e-05	0.000172	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD3B1—prostate cancer	2.07e-05	0.000171	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC22A3—prostate cancer	2.07e-05	0.000171	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.01e-05	0.000166	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA4—prostate cancer	2e-05	0.000165	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TBXAS1—prostate cancer	2e-05	0.000165	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA4—prostate cancer	1.98e-05	0.000164	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TBXAS1—prostate cancer	1.98e-05	0.000164	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA2—prostate cancer	1.95e-05	0.000161	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.94e-05	0.00016	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA2—prostate cancer	1.93e-05	0.000159	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SULT1A1—prostate cancer	1.92e-05	0.000159	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCG5—prostate cancer	1.92e-05	0.000159	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCG5—prostate cancer	1.91e-05	0.000157	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SULT1A1—prostate cancer	1.91e-05	0.000157	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA1—prostate cancer	1.88e-05	0.000155	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA1—prostate cancer	1.86e-05	0.000154	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTO1—prostate cancer	1.86e-05	0.000153	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD3B2—prostate cancer	1.86e-05	0.000153	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NAT2—prostate cancer	1.86e-05	0.000153	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NAT2—prostate cancer	1.84e-05	0.000152	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTO1—prostate cancer	1.84e-05	0.000152	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD3B2—prostate cancer	1.84e-05	0.000152	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLCB2—prostate cancer	1.78e-05	0.000147	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LRP2—prostate cancer	1.78e-05	0.000147	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2C18—prostate cancer	1.78e-05	0.000147	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.77e-05	0.000146	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLCB2—prostate cancer	1.77e-05	0.000146	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LRP2—prostate cancer	1.77e-05	0.000146	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2C18—prostate cancer	1.77e-05	0.000146	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—P4HB—prostate cancer	1.75e-05	0.000144	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—P4HB—prostate cancer	1.73e-05	0.000143	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC22A1—prostate cancer	1.7e-05	0.00014	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC22A1—prostate cancer	1.69e-05	0.000139	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.67e-05	0.000137	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SULT2A1—prostate cancer	1.66e-05	0.000137	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SULT2A1—prostate cancer	1.64e-05	0.000136	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MED12—prostate cancer	1.63e-05	0.000135	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GNG5—prostate cancer	1.62e-05	0.000133	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MED12—prostate cancer	1.62e-05	0.000133	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GNG5—prostate cancer	1.6e-05	0.000132	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOA3—prostate cancer	1.56e-05	0.000129	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOA3—prostate cancer	1.54e-05	0.000127	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.52e-05	0.000125	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HPGDS—prostate cancer	1.49e-05	0.000123	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2C19—prostate cancer	1.48e-05	0.000122	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HPGDS—prostate cancer	1.47e-05	0.000122	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2C19—prostate cancer	1.46e-05	0.000121	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ACHE—prostate cancer	1.44e-05	0.000119	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTT1—prostate cancer	1.44e-05	0.000119	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTT1—prostate cancer	1.43e-05	0.000118	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ACHE—prostate cancer	1.43e-05	0.000118	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2A6—prostate cancer	1.42e-05	0.000118	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2A6—prostate cancer	1.41e-05	0.000117	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.41e-05	0.000116	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKR1C3—prostate cancer	1.39e-05	0.000114	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PRKACB—prostate cancer	1.38e-05	0.000114	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.37e-05	0.000113	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PRKACB—prostate cancer	1.37e-05	0.000113	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.36e-05	0.000113	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP17A1—prostate cancer	1.35e-05	0.000112	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.33e-05	0.00011	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOA2—prostate cancer	1.3e-05	0.000107	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOA2—prostate cancer	1.29e-05	0.000106	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.24e-05	0.000102	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.23e-05	0.000101	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.21e-05	0.0001	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.2e-05	9.91e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NQO1—prostate cancer	1.2e-05	9.89e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NQO1—prostate cancer	1.19e-05	9.8e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TH—prostate cancer	1.18e-05	9.74e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TH—prostate cancer	1.17e-05	9.66e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.17e-05	9.64e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.16e-05	9.6e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.16e-05	9.56e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.15e-05	9.51e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.15e-05	9.48e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.14e-05	9.4e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GGT1—prostate cancer	1.11e-05	9.18e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GGT1—prostate cancer	1.1e-05	9.1e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOA1—prostate cancer	1.1e-05	9.04e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOA1—prostate cancer	1.09e-05	8.96e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.08e-05	8.91e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.07e-05	8.83e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—RXRA—prostate cancer	1.04e-05	8.6e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—RXRA—prostate cancer	1.03e-05	8.53e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1e-05	8.29e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—COMT—prostate cancer	1e-05	8.28e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTP1—prostate cancer	9.99e-06	8.24e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—COMT—prostate cancer	9.95e-06	8.21e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTP1—prostate cancer	9.9e-06	8.17e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ITPR1—prostate cancer	9.83e-06	8.11e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ITPR1—prostate cancer	9.75e-06	8.04e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.58e-06	7.91e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TYMS—prostate cancer	9.29e-06	7.66e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TYMS—prostate cancer	9.21e-06	7.6e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTM1—prostate cancer	9.18e-06	7.58e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTM1—prostate cancer	9.1e-06	7.51e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LPL—prostate cancer	9.01e-06	7.44e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LPL—prostate cancer	8.93e-06	7.37e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP1A1—prostate cancer	8.7e-06	7.18e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ERCC2—prostate cancer	8.63e-06	7.12e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP1A1—prostate cancer	8.63e-06	7.12e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ERCC2—prostate cancer	8.56e-06	7.06e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTHFR—prostate cancer	8.11e-06	6.7e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTHFR—prostate cancer	8.04e-06	6.64e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARA—prostate cancer	7.96e-06	6.57e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARA—prostate cancer	7.89e-06	6.51e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CAV1—prostate cancer	7.48e-06	6.18e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CAV1—prostate cancer	7.42e-06	6.12e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.09e-06	5.85e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CG—prostate cancer	6.82e-06	5.63e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CG—prostate cancer	6.76e-06	5.58e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—INS—prostate cancer	6.45e-06	5.33e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—INS—prostate cancer	6.4e-06	5.28e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CREBBP—prostate cancer	6.32e-06	5.22e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CREBBP—prostate cancer	6.27e-06	5.17e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CD—prostate cancer	5.99e-06	4.95e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CD—prostate cancer	5.94e-06	4.9e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NOS3—prostate cancer	5.66e-06	4.67e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NOS3—prostate cancer	5.61e-06	4.63e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.22e-06	4.31e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.18e-06	4.27e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS2—prostate cancer	5.18e-06	4.27e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS2—prostate cancer	5.13e-06	4.23e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTEN—prostate cancer	4.51e-06	3.72e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTEN—prostate cancer	4.47e-06	3.69e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—EP300—prostate cancer	4.3e-06	3.55e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—EP300—prostate cancer	4.27e-06	3.52e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.18e-06	2.63e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.16e-06	2.61e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKT1—prostate cancer	2.6e-06	2.15e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKT1—prostate cancer	2.58e-06	2.13e-05	CbGpPWpGaD
